Back

Current echocardiographic indices for right ventricular function are inadequate to predict patient outcomes in chronic tricuspid regurgitation

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: What’s new in imaging of valvular heart disease Systolic and Diastolic Function ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Charlotte Lee Frost

Brigham and Women's Hospital, Boston (United States of America)

5 More presentations in this session

Presentation thumbnail
Prognostic preoperative factors for recurrence of tricuspid regurgitation following annuloplasty: examining the influence of 3d echocardiography
Mr D. Verikas (Kaunas, LT)
Abstract Slides Video
Presentation thumbnail
Prognostic value of right ventricular-pulmonary arterial coupling indices in patients with moderate to severe mitral stenosis
Doctor M. Chan (Selangor, MY)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of aortic valve displacement by tissue tracking for identification of aortic valve stenosis severity.
Doctor A. Jasinska (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Evolution and prognostic impact of left ventricular myocardial work indices after transcatheter aortic valve replacement in patients with severe aortic stenosis
Miss H. Wu (Leiden, NL)
Abstract Slides Video
Presentation thumbnail
Echocardiographic assessment of the right heart pulmonary circulation unit in mitral regurgitation due to mitral valve prolapse
Doctor R. Maheut (Nancy, FR)
Abstract Slides Video

Access the full session

Session thumbnail
What’s new in imaging of valvular heart disease
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Diastolic function and left atrial pressures
thumbnail
Congress Presentation
LV diastolic function: how to deal with challenges
thumbnail
Congress Presentation
Evaluation of diastolic function and LV filling pressures: limitations of current guidelines 

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources